Metraipolis › archive › dc_c065166d39af

Impact of biologic therapy on blood cell indices and exacerbation risk in severe asthma: predictive value of the neutrophil-to-eosinophil ratio — Europe PMC PMID:41278227

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41278227
DOI: 10.3389/falgy.2025.1691886
License (as archived): solo-consultazione
Archived: 2026-11-08T17:35:15.628Z
SHA-256 of the archived text: a4f97c93bedf2eb463cd12041fe0a0b26b344bd1fef79f721ad40aba6b62add3
Stable URL of this page: https://metraipolis.com/documento/dc_c065166d39af

How to cite

Impact of biologic therapy on blood cell indices and exacerbation risk in severe asthma: predictive value of the neutrophil-to-eosinophil ratio — Europe PMC PMID:41278227 — Europe PMC (en), https://europepmc.org/article/MED/41278227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c065166d39af (Metraipolis archive dc_c065166d39af, sha256 a4f97c93bedf2eb463cd12041fe0a0b26b344bd1fef79f721ad40aba6b62add3)

BibTeX

@misc{dcc065166d39af,
  title = {Impact of biologic therapy on blood cell indices and exacerbation risk in severe asthma: predictive value of the neutrophil-to-eosinophil ratio — Europe PMC PMID:41278227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41278227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c065166d39af; sha256 a4f97c93bedf2eb463cd12041fe0a0b26b344bd1fef79f721ad40aba6b62add3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41278227. Agents can read the archived copy with the MCP tool read_document.